LBA63 Placebo-controlled, double-blinded phase Ⅲ study comparing dexamethasone on day 1 with dexamethasone on days 1 to 4, with combined neurokinin-1 receptor antagonist, palonosetron, and olanzapine in patients receiving cisplatin-containing highly emetogenic chemotherapy: SPARED trial
K. Shimomura; H. Minatogawa; T. Mashiko; H. Arioka; H. Iihara; M. Sugawara; N. Hida; K. Akiyama; S. Nawata; A. Tsuboya; K. Mishima; N. Izawa; T. Miyaji; K. Honda; Y. Inada; Y. Ohno; C. Katada; H. Morita; T. Yamaguchi; T.E. Nakajima
Annals of Oncology, 2021年09月